Skip to main content
. 2017 May 30;16:101. doi: 10.1186/s12944-017-0499-1

Table 6.

Hepatic and kidney condition and serum mineral levels

Intake Period (Weeks)
Groups n 0 4 8
AST (IU/L) 8 g 29 20.1 ± 0.9 20.3 ± 0.8 20.8 ± 0.8
6 g 31 20.3 ± 1.0 20.8 ± 1.0 20.9 ± 1.2
4 g 28 22.9 ± 1.5 21.8 ± 1.1 21.8 ± 1.1
ALT (IU/L) 8 g 29 24.2 ± 1.8 23.7 ± 1.7 24.1 ± 1.7
6 g 31 25.6 ± 2.0 24.8 ± 2.3 24.7 ± 2.0
4 g 28 27.6 ± 2.3 25.3 ± 2.4 27.4 ± 2.6
γ-GTP (IU/L) 8 g 29 40.7 ± 4.6 40.4 ± 4.8 42.6 ± 4.9
6 g 31 37.9 ± 4.0 35.8 ± 3.4 35.7 ± 3.9
4 g 28 39.1 ± 3.6 40.0 ± 4.1 42.1 ± 5.1
BUN (mg/dL) 8 g 29 12.4 ± 0.5 13.7 ± 0.5* 13.2 ± 0.5
6 g 31 13.8 ± 0.6 14.9 ± 0.7 14.6 ± 0.6
4 g 28 13.4 ± 0.7 13.9 ± 0.6 13.3 ± 0.5
Cr (mg/dL) 8 g 29 0.820 ± 0.020 0.822 ± 0.021 0.829 ± 0.023
6 g 31 0.791 ± 0.015 0.795 ± 0.016 0.791 ± 0.015
4 g 28 0.814 ± 0.016 0.811 ± 0.015 0.811 ± 0.013
UA (mg/dL) 8 g 29 6.09 ± 0.18 6.03 ± 0.17 6.10 ± 0.21
6 g 31 6.15 ± 0.17 6.11 ± 0.18 6.02 ± 0.15
4 g 28 6.02 ± 0.22 6.00 ± 0.23 6.07 ± 0.24
Na (mg/dL) 8 g 29 142 ± 0 142 ± 0 142 ± 0
6 g 31 142 ± 0 142 ± 0 142 ± 0
4 g 28 142 ± 0 142 ± 0 142 ± 0*
K (mg/dL) 8 g 29 4.10 ± 0.05 4.11 ± 0.04 4.20 ± 0.05
6 g 31 4.16 ± 0.05 4.07 ± 0.04 4.22 ± 0.04
4 g 28 4.24 ± 0.06 4.16 ± 0.05 4.19 ± 0.04
Cl (mg/dL) 8 g 29 103 ± 0 103 ± 0 104 ± 0
6 g 31 103 ± 0 103 ± 0 104 ± 0
4 g 28 103 ± 0 103 ± 0 104 ± 0*
Ca (mg/dL) 8 g 29 9.43 ± 0.05 9.33 ± 0.07 9.24 ± 0.06*
6 g 31 9.32 ± 0.05 9.24 ± 0.06 9.26 ± 0.04
4 g 28 9.43 ± 0.05 9.34 ± 0.06 9.34 ± 0.06

Mean ± SE of 29 (8 g), 31 (6 g), and 28 (4 g), *: p < 0.05 vs. 0 weeks by Dunnett test